Recap: Aeglea BioTherapeutics Q3 Earnings


Aeglea BioTherapeutics AGLE reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Aeglea BioTherapeutics beat estimated earnings by 17.39%, reporting an EPS of $-0.19 versus an estimate of $-0.23.

Revenue was down $1.23 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 1.23% increase in the share price the next day.


To track all earnings releases for Aeglea BioTherapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!